The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gould, M. P.
Right arrow Articles by Heinzel, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gould, M. P.
Right arrow Articles by Heinzel, F. P.
The Journal of Immunology, 2004, 172: 1754-1762.
Copyright © 2004 by The American Association of Immunologists

Distinct Modulatory Effects of LPS and CpG on IL-18-Dependent IFN-{gamma} Synthesis1

Meetha P. Gould*, Jennifer A. Greene*, Vijay Bhoj*, Jennifer L. DeVecchio*,{dagger} and Frederick P. Heinzel2,*,{dagger}

* Center for Global Health and Diseases, Case Western Reserve University, and {dagger} Medical Research Service, Cleveland Veterans Affairs Medical Center, Cleveland, OH 41106

Innate cellular production of IFN-{gamma} is suppressed after repeated exposure to LPS, whereas CpG-containing DNA potentiates IFN-{gamma} production. We compared the modulatory effects of LPS and CpG on specific cellular and cytokine responses necessary for NK-cell dependent IFN-{gamma} synthesis. C3H/HeN mice pretreated with LPS for 2 days generated 5-fold less circulating IL-12 p70 and IFN-{gamma} in response to subsequent LPS challenge than did challenged control mice. In contrast, CpG-pretreated mice produced 10-fold more circulating IFN-{gamma} without similar changes in IL-12 p70 levels, but with 10-fold increases in serum IL-18 relative to LPS-challenged control or endotoxin-tolerant mice. The role of IL-18 in CpG-induced immune potentiation was studied in splenocyte cultures from control, LPS-conditioned, or CpG-conditioned mice. These cultures produced similar amounts of IFN-{gamma} in response to rIL-12 and rIL-18. However, only CpG-conditioned cells produced IFN-{gamma} when cultured with LPS or CpG, and production was ablated in the presence of anti-IL-18R Ab. Anti-IL-18R Ab also reduced in vivo IFN-{gamma} production by >2-fold in CpG-pretreated mice. Finally, combined pretreatment of mice with LPS and CpG suppressed the production of circulating IFN-{gamma}, IL-12 p70, and IL-18 after subsequent LPS challenge. We conclude that CpG potentiates innate IFN-{gamma} production from NK cells by increasing IL-18 availability, but that the suppressive effects of LPS on innate cellular immunity dominate during combined LPS and CpG pretreatment. Multiple Toll-like receptor engagement in vivo during infection can result in functional polarization of innate immunity dominated by a specific Toll-like receptor response.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Zhou, H. Wei, R. Sun, J. Zhang, and Z. Tian
NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice
PNAS, May 1, 2007; 104(18): 7512 - 7515.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Greene, J. L. DeVecchio, M. P. Gould, J. J. Auletta, and F. P. Heinzel
In vivo and In vitro Regulation of Type I IFN Synthesis by Synergistic Effects of CD40 and Type II IFN
J. Immunol., May 15, 2006; 176(10): 5995 - 6003.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Kahlenberg, K. C. Lundberg, S. B. Kertesy, Y. Qu, and G. R. Dubyak
Potentiation of Caspase-1 Activation by the P2X7 Receptor Is Dependent on TLR Signals and Requires NF-{kappa}B-Driven Protein Synthesis
J. Immunol., December 1, 2005; 175(11): 7611 - 7622.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Suzuki, D. Wakita, K. Chamoto, Y. Narita, T. Tsuji, T. Takeshima, H. Gyobu, Y. Kawarada, S. Kondo, S. Akira, et al.
Liposome-Encapsulated CpG Oligodeoxynucleotides as a Potent Adjuvant for Inducing Type 1 Innate Immunity
Cancer Res., December 1, 2004; 64(23): 8754 - 8760.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Wongratanacheewin, W. Kespichayawattana, P. Intachote, S. Pichyangkul, R. W. Sermswan, A. M. Krieg, and S. Sirisinha
Immunostimulatory CpG Oligodeoxynucleotide Confers Protection in a Murine Model of Infection with Burkholderia pseudomallei
Infect. Immun., August 1, 2004; 72(8): 4494 - 4502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.